The cytokines of the body’s immune system, such as TNF-α, INF-α and IL-2, can reduce the expression levels of MDR1 gene mRNA and P-gp, increase the sensitivity of breast cancer cells to neoadjuvant chemotherapy drugs, and reverse resistance to neoadjuvant chemotherapy drugs [150]. This evidence concerns the gene PGP and breast cancer.